Thehorse.com - Full Article
by: Kimberly S. Brown, Editor
November 23 2009, Article # 15334
New equine West Nile virus vaccines have been approved by the USDA. The vaccine line, called Vetera, is manufactured by Boehringer-Ingelheim, a privately held pharmaceutical company.
The Vetera line of West Nile virus vaccines "is the first new approach to a killed West Nile virus vaccine since 2001," stated Bob Stenbom, DVM, associate director of Equine Professional Services for Boehringer-Ingelheim.
There are three new vaccines in the Vetera West Nile virus line. The first is a monovalent that contains only a vaccine against West Nile virus. The second combines West Nile virus vaccine with Eastern equine encephalitis (EEE), Western equine encephalitis (WEE), and tetanus. The third vaccine combines all of the aforementioned plus Venezuelan equine encephalitis (VEE).